Aptinyx Inc. financial data

Industry
Pharmaceutical Preparations
Location
1801 Maple Avenue, Suite 4300, Evanston, IL
State of incorporation
DE
Fiscal year end
December 31

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.16K % -52.3%
Debt-to-equity 69.1 % +291%
Return On Equity -158 % -104%
Return On Assets -93.4 % -41.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 67.7M shares 0%
Common Stock, Shares, Outstanding 67.7M shares 0%
Common Stock, Value, Issued 677K USD 0%
Weighted Average Number of Shares Outstanding, Basic 67.7M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 67.7M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 45.2M USD -23%
General and Administrative Expense 18.3M USD -12.5%
Operating Income (Loss) -63.5M USD +20.2%
Net Income (Loss) Attributable to Parent -66.1M USD +17.9%
Earnings Per Share, Basic -0.98 USD/shares +16.9%
Earnings Per Share, Diluted -0.98 USD/shares +16.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 44.6M USD -55.5%
Other Assets, Current 378K USD +41%
Assets, Current 47.8M USD -55.2%
Property, Plant and Equipment, Net 32K USD -82.7%
Operating Lease, Right-of-Use Asset 305K USD
Other Assets, Noncurrent 206K USD
Assets 48M USD -55%
Accounts Payable, Current 1.37M USD -21.6%
Employee-related Liabilities, Current 256K USD -66.3%
Liabilities, Current 9.32M USD +96.8%
Other Liabilities, Noncurrent 10K USD -96.5%
Liabilities 29.7M USD +1.84%
Retained Earnings (Accumulated Deficit) -374M USD -21.5%
Stockholders' Equity Attributable to Parent 18.3M USD -76.4%
Liabilities and Equity 48M USD -55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.4M USD +28.6%
Net Cash Provided by (Used in) Financing Activities -267K USD -103%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 67.7M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 44.8M USD -55.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 822K USD +176%
Deferred Tax Assets, Valuation Allowance 91M USD +24.8%
Deferred Tax Assets, Gross 91.1M USD +25%
Operating Lease, Liability 337K USD
Lessee, Operating Lease, Liability, to be Paid 347K USD
Operating Lease, Liability, Current 337K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 347K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10K USD
Deferred Tax Assets, Operating Loss Carryforwards 70.1M USD +8.14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 300K USD +50%
Additional Paid in Capital 391M USD +1.78%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 32K USD -15.8%
Deferred Tax Assets, Net of Valuation Allowance 87K USD
Share-based Payment Arrangement, Expense 6.86M USD -27.1%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%